Clinical Trial Update: S-32 PG 242 Short Stem

View source ↗

Summary

A completed clinical trial evaluating the S-32 PG 242 Short Stem for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• S-32 PG 242 Short Stem

Snippet

Sponsor: St. Louis Joint Replacement Institute | Conditions: Osteoporosis | Status: COMPLETED